vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Sezzle Inc.（SEZL）财务数据对比。点击上方公司名可切换其他公司
Sezzle Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$78.2M vs $75.5M），Sezzle Inc.同比增速更快（61.6% vs 27.7%），Sezzle Inc.自由现金流更多（$70.6M vs $14.4M），过去两年Sezzle Inc.的营收复合增速更高（76.0% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Sezzle是一家总部位于美国明尼阿波利斯的上市金融科技企业，业务覆盖美国与加拿大。公司主打先享后付支付平台，为合作线上商家的消费者提供零息分期支付解决方案。截至2021年6月，平台注册用户超1000万，合作商户数量超4.8万家。
PBYI vs SEZL — 直观对比
营收规模更大
SEZL
是对方的1.0倍
$75.5M
营收增速更快
SEZL
高出33.9%
27.7%
自由现金流更多
SEZL
多$56.2M
$14.4M
两年增速更快
SEZL
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $78.2M |
| 净利润 | — | $42.7M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 70.6% |
| 净利率 | — | 54.6% |
| 营收同比 | 27.7% | 61.6% |
| 净利润同比 | — | 68.3% |
| 每股收益（稀释后） | $0.26 | $1.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISEZL
| Q4 25 | $75.5M | $78.2M | ||
| Q3 25 | $54.5M | $57.5M | ||
| Q2 25 | $52.4M | $52.0M | ||
| Q1 25 | $46.0M | $48.2M | ||
| Q4 24 | $59.1M | $48.4M | ||
| Q3 24 | $80.5M | $35.6M | ||
| Q2 24 | $47.1M | $30.2M | ||
| Q1 24 | $43.8M | $25.2M |
净利润PBYISEZL
| Q4 25 | — | $42.7M | ||
| Q3 25 | $8.8M | $26.7M | ||
| Q2 25 | $5.9M | $27.6M | ||
| Q1 25 | $3.0M | $36.2M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | $20.3M | $15.4M | ||
| Q2 24 | $-4.5M | $29.7M | ||
| Q1 24 | $-4.8M | $8.0M |
毛利率PBYISEZL
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISEZL
| Q4 25 | 22.7% | 70.6% | ||
| Q3 25 | 17.6% | 61.9% | ||
| Q2 25 | 12.7% | 69.4% | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | 63.8% | ||
| Q3 24 | 27.4% | 58.6% | ||
| Q2 24 | -4.6% | 55.3% | ||
| Q1 24 | -5.3% | 54.8% |
净利率PBYISEZL
| Q4 25 | — | 54.6% | ||
| Q3 25 | 16.2% | 46.4% | ||
| Q2 25 | 11.2% | 53.1% | ||
| Q1 25 | 6.5% | 75.1% | ||
| Q4 24 | — | 52.4% | ||
| Q3 24 | 25.2% | 43.4% | ||
| Q2 24 | -9.6% | 98.4% | ||
| Q1 24 | -11.0% | 31.7% |
每股收益（稀释后）PBYISEZL
| Q4 25 | $0.26 | $1.19 | ||
| Q3 25 | $0.17 | $0.75 | ||
| Q2 25 | $0.12 | $0.78 | ||
| Q1 25 | $0.06 | $1.00 | ||
| Q4 24 | $0.40 | $0.71 | ||
| Q3 24 | $0.41 | $0.44 | ||
| Q2 24 | $-0.09 | $0.82 | ||
| Q1 24 | $-0.10 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $64.1M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $169.8M |
| 总资产 | $216.3M | $400.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISEZL
| Q4 25 | $97.5M | $64.1M | ||
| Q3 25 | $94.4M | $104.1M | ||
| Q2 25 | $96.0M | $88.9M | ||
| Q1 25 | $93.2M | $88.9M | ||
| Q4 24 | $101.0M | $73.2M | ||
| Q3 24 | $96.7M | $80.1M | ||
| Q2 24 | $96.8M | $58.0M | ||
| Q1 24 | $107.2M | $77.8M |
总债务PBYISEZL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYISEZL
| Q4 25 | $130.3M | $169.8M | ||
| Q3 25 | $115.3M | $155.3M | ||
| Q2 25 | $104.7M | $130.4M | ||
| Q1 25 | $97.1M | $125.8M | ||
| Q4 24 | $92.1M | $87.8M | ||
| Q3 24 | $71.1M | $61.1M | ||
| Q2 24 | $48.5M | $50.3M | ||
| Q1 24 | $51.0M | $29.6M |
总资产PBYISEZL
| Q4 25 | $216.3M | $400.2M | ||
| Q3 25 | $202.9M | $367.0M | ||
| Q2 25 | $194.9M | $350.6M | ||
| Q1 25 | $196.2M | $298.1M | ||
| Q4 24 | $213.3M | $298.4M | ||
| Q3 24 | $220.7M | $252.9M | ||
| Q2 24 | $205.0M | $212.1M | ||
| Q1 24 | $214.1M | $195.7M |
负债/权益比PBYISEZL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $70.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $70.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 90.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 1.65× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $209.3M |
8季度趋势，按日历期对齐
经营现金流PBYISEZL
| Q4 25 | $14.4M | $70.6M | ||
| Q3 25 | $9.7M | $63.7M | ||
| Q2 25 | $14.1M | $23.1M | ||
| Q1 25 | $3.6M | $52.5M | ||
| Q4 24 | $15.6M | $57.4M | ||
| Q3 24 | $11.0M | $35.1M | ||
| Q2 24 | $1.0M | $22.2M | ||
| Q1 24 | $11.2M | $16.0M |
自由现金流PBYISEZL
| Q4 25 | $14.4M | $70.6M | ||
| Q3 25 | $9.7M | $63.6M | ||
| Q2 25 | $14.1M | $22.7M | ||
| Q1 25 | $3.6M | $52.5M | ||
| Q4 24 | $15.6M | $57.4M | ||
| Q3 24 | $11.0M | $35.1M | ||
| Q2 24 | $1.0M | $22.2M | ||
| Q1 24 | — | $16.0M |
自由现金流率PBYISEZL
| Q4 25 | 19.1% | 90.2% | ||
| Q3 25 | 17.7% | 110.6% | ||
| Q2 25 | 26.8% | 43.6% | ||
| Q1 25 | 7.7% | 108.9% | ||
| Q4 24 | 26.4% | 118.5% | ||
| Q3 24 | 13.7% | 98.6% | ||
| Q2 24 | 2.1% | 73.4% | ||
| Q1 24 | — | 63.3% |
资本支出强度PBYISEZL
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率PBYISEZL
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.10× | 2.39× | ||
| Q2 25 | 2.41× | 0.84× | ||
| Q1 25 | 1.21× | 1.45× | ||
| Q4 24 | — | 2.26× | ||
| Q3 24 | 0.54× | 2.27× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SEZL
| Merchant And Partner Income | $28.9M | 37% |
| Transaction Income | $25.9M | 33% |
| Income From Other Services Late Payment Fees | $20.5M | 26% |
| Other | $2.9M | 4% |
